Novo Nordisk A/S (NYSE:NVO) Rating Lowered to Neutral at JPMorgan Chase & Co.
Novo Nordisk A/S (NYSE:NVO – Get Free Report) was downgraded by investment analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating in a research report issued to clients and investors on Tuesday, MarketBeat reports. NVO has been the topic of several other research reports. Zacks Research cut shares of Novo [...]